Trial Profile
An observational, open label study evaluating plasma concentrations of darunavir/ritonavir and raltegravir in older patients as compared to younger patients with HIV-1 infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2018
Price :
$35
*
At a glance
- Drugs Darunavir/ritonavir (Primary) ; Emtricitabine/tenofovir (Primary) ; Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 29 Mar 2018 New trial record